Published in Dev Ophthalmol on April 17, 2012
Immunopathogenesis of ocular Behçet's disease. J Immunol Res (2014) 0.83
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Subtenon injection of natural leukocyte interferon α-2a in diabetic macular edema: a case report. BMC Ophthalmol (2013) 0.78
Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem. Curr Neuropharmacol (2016) 0.75
[Intermediate uveitis: guidelines of the German Ophthalmological Society and the Professional Association of German Ophthalmologists]. Ophthalmologe (2014) 0.75
[Therapy of intermediate uveitis]. Ophthalmologe (2014) 0.75
[Differential diagnosis of anterior uveitis]. Ophthalmologe (2016) 0.75
Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum (2010) 1.84
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology (2013) 1.81
Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol (2006) 1.47
The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum (2004) 1.44
Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res (2011) 1.35
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology (2010) 1.34
Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm (2009) 1.25
The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis. Br J Ophthalmol (2010) 1.25
Behçet's disease: ocular effects and treatment. Prog Retin Eye Res (2007) 1.17
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial. Semin Arthritis Rheum (2004) 1.17
Rosacea - S1 guideline. J Dtsch Dermatol Ges (2013) 1.06
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol (2007) 1.00
Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm (2011) 0.96
[Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome)]. Klin Monbl Augenheilkd (2002) 0.91
Uveitis in children. Int Ophthalmol Clin (2005) 0.90
Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study. Retina (2006) 0.86
Light on the horizont: biologicals in Behçet uveitis. Acta Ophthalmol (2012) 0.86
Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol (2014) 0.86
Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis. Adv Exp Med Biol (2003) 0.85
Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol (2004) 0.85
Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm (2014) 0.84
Current medical treatment of ocular mucous membrane pemphigoid. Ocul Surf (2013) 0.83
CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases. Clin Rheumatol (2005) 0.83
New pharmacotherapy options for noninfectious posterior uveitis. Expert Opin Biol Ther (2014) 0.83
Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.82
Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea (2014) 0.82
Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm (2009) 0.81
Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol (2008) 0.81
Amphotericin B in the therapy of Candida glabrata endophthalmitis after penetrating keratoplasty. Cornea (2006) 0.81
Controversies in Behçet disease. Ocul Immunol Inflamm (2012) 0.80
The creeping choroiditides - serpiginous and multifocal serpiginoid choroiditis. Ocul Immunol Inflamm (2014) 0.80
The good, the bad and the ugly--APCs of the eye. Trends Immunol (2003) 0.80
Intraocular lymphoma: more questions than answers. Ocul Immunol Inflamm (2009) 0.79
Necrotizing herpetic retinitis. Ocul Immunol Inflamm (2014) 0.79
Therapy of uveitis in children. Int Ophthalmol Clin (2008) 0.79
High incidence of antibodies to lens proteins in sera from patients with uveitis. Graefes Arch Clin Exp Ophthalmol (2006) 0.79
An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis. Ocul Immunol Inflamm (2008) 0.79
Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period. Pediatr Dermatol (2010) 0.78
Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases. Ocul Immunol Inflamm (2011) 0.78
Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN. J Rheumatol (2005) 0.78
Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease. Adv Exp Med Biol (2003) 0.78
Interferon alpha 2a in IRPB-derived peptide-induced EAU--part I. Adv Exp Med Biol (2003) 0.78
Controversies in ocular inflammation and immunology laser flare photometry. Ocul Immunol Inflamm (2010) 0.78
Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture. Ocul Immunol Inflamm (2010) 0.78
Identification of immunodominant epitopes of alpha-crystallins recognized by antibodies in sera of patients with uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.77
Treatment of ocular rosacea with 40 mg doxycycline in a slow release form. J Dtsch Dermatol Ges (2011) 0.77
Uveitis treatment trials--a cross-study perspective. Ocul Immunol Inflamm (2012) 0.77
Tubulointerstitial nephritis and uveitis in siblings. Ocul Immunol Inflamm (2010) 0.76
Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid. Ocul Immunol Inflamm (2011) 0.76
Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a. Adv Exp Med Biol (2003) 0.76
Controversies in intraocular lymphoma. Ocul Immunol Inflamm (2009) 0.76
Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective. Ocul Immunol Inflamm (2015) 0.76
Controversy: ocular sarcoidosis. Ocul Immunol Inflamm (2010) 0.76
Mycophenolate mofetil in the therapy of uveitic macular edema--long-term results. Ocul Immunol Inflamm (2012) 0.76
Sarcoid uveitis. Ocul Immunol Inflamm (2014) 0.76
The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action. Adv Exp Med Biol (2003) 0.75
Therapeutic implications for interferon-alpha in arthritis. J Rheumatol (2004) 0.75
TNF inhibitors for uveitis: balancing efficacy and safety. Ocul Immunol Inflamm (2010) 0.75
The promise and limitations of TNF-α inhibition for uveitis. Ocul Immunol Inflamm (2014) 0.75
Correction: Subretinal Fluid in Eyes with Active Ocular Toxoplasmosis Observed Using Spectral Domain Optical Coherence Tomography. PLoS One (2015) 0.75
Drug-induced inflammation in patients on TNFα inhibitors. Ocul Immunol Inflamm (2012) 0.75
Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome? Graefes Arch Clin Exp Ophthalmol (2014) 0.75
EBV-induced polymorphic lymphoproliferative disorder of the iris after heart transplantation. Graefes Arch Clin Exp Ophthalmol (2003) 0.75
Editorial 2010 for ocular immunology and inflammation. Ocul Immunol Inflamm (2010) 0.75
Ocular Toxoplasmosis. Ocul Immunol Inflamm (2015) 0.75
Spectral-domain-optical coherence tomography in uveitis. Ocul Immunol Inflamm (2014) 0.75
Behçet's disease in patients of German and Turkish origin--a comparative study. Adv Exp Med Biol (2003) 0.75
The first edition of Ocular Immunologyand Inflammation for 2012. Ocul Immunol Inflamm (2012) 0.75
[Rainbow colored halo: what causes it?]. MMW Fortschr Med (2013) 0.75
Ocular Immunology and Inflammation. Editorial. Ocul Immunol Inflamm (2009) 0.75
International Uveitis-Expert-Network: a web based platform on the Internet. Graefes Arch Clin Exp Ophthalmol (2002) 0.75
Behçet's disease: visual acuity after 5 years in patients with alpha-interferon treatment. Adv Exp Med Biol (2003) 0.75
Editorial 2013 for Ocular Immunology and Inflammation. Ocul Immunol Inflamm (2013) 0.75
Tuberculous uveitis. Ocul Immunol Inflamm (2015) 0.75
Editorial 2014. Ocul Immunol Inflamm (2014) 0.75